Use access key #2 to skip to page content.
$1.40 0.04 (2.94%)
11/21/2008 4:00 PM

Akorn, Inc. (AKRX)

CAPS Rating:
**

The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

AKRX doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

56 Outperforms
12 Underperforms
 

All-Stars

9 Outperforms
4 Underperforms
 

Members bullish on AKRX are also bullish on:

Members bearish on AKRX are also bearish on:

Ticker Tags

Micro Cap (5043), Pharmaceuticals (148)
Suggest a tag

Akorn, Inc. At A Glance

Current Price: $1.40
Last Trade Time: 11/21/2008 4:00 PM
Open: $1.38
Previous Close: $1.36
Daily Range: $1.11 - $1.41
52-Week Range: $1.36 - $8.19
Volume: 425,802
Market Cap: $121.47M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

AKRX VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for AKRX

More Headlines...

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

Recs

0

Akorn, Inc. (AKRX)

Avatar OriginalBarnacle (37.84) Submitted: 8/23/07 2:01 PM

P/b = 10.2


P/S = 12.7


No earnings


Margins are worse with increasing inventory.


Price change over 106%


Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 9 :   1 2 Next »

Recs

0

 (AKRX)

Avatar Hybr1d1nevstor (52.75) Submitted: 5/15/08 11:56 PM : Outperform Start Price: $4.42 AKRX Score: -21.44

Akorn is starting to get their name out there more an is currently in the works of a few brand name products. Although they do not mnfr. their own products they have well established companies that do. I work for a pharmaceutical distributor and we are starting to sell their new Tetanus Diptheria. According to an inservice we just had with Akorn they plan to keep their Tetanus Diptheria always priced lower than its competitor. Just hitting a 52 week low today and bouncing back already this stock I think will double by the end of 2008 and will go higher long term.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AKRX)

Avatar rodwiller (< 20) Submitted: 9/26/07 6:14 PM : Outperform Start Price: $7.79 AKRX Score: -31.62

This stock will be at $20/share by mid 2008

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AKRX)

Avatar OriginalBarnacle (37.84) Submitted: 8/23/07 2:01 PM : Underperform Start Price: $7.55 AKRX Score: 33.21

P/b = 10.2


P/S = 12.7


No earnings


Margins are worse with increasing inventory.


Price change over 106%


Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AKRX)

Avatar mackfack (96.54) Submitted: 1/19/07 4:24 PM : Outperform Start Price: $6.10 AKRX Score: -30.05

niche therapeutic provider for opthamology and rhematology

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AKRX)

Avatar dew2105 (82.07) Submitted: 1/09/07 8:30 PM : Outperform Start Price: $5.90 AKRX Score: -30.22

looks solid

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 9 :   1 2 Next »

Wall Street

picks per page. CHANGE

Sorry, no results found.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links